Form 4: Vita Coco Director Sells 30,000 Shares Under 10b5-1 Plan

Vita Coco Company Director Ira Liran sold 30,000 shares of common stock for approximately $1.08 million under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Ira Liran, a Director of Vita Coco Company, Inc. (COCO), sold 30,000 shares of common stock.
• The transaction occurred on August 20, 2025, at a weighted average price of $36.08 per share, with prices ranging from $36.00 to $36.30.
• The total value of the shares sold is approximately $1,082,400.
• The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
• Following the transaction, Ira Liran directly beneficially owns 638,341 shares and indirectly owns 782,579 shares through the Ira Liran 2012 Family Trust.

Sentiment

Score: 4

Explanation: The sale of 30,000 shares by a director, while executed under a pre-arranged 10b5-1 plan, represents a reduction in insider ownership. While not necessarily indicative of a negative outlook, it doesn't signal strong conviction or increased alignment with shareholders.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than an immediate reaction to new, undisclosed information, which can suggest a planned diversification or liquidity event.

Negatives

• A director selling a significant number of shares (30,000 shares) could be perceived negatively by some investors, potentially signaling a reduction in insider exposure.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

This filing, a routine insider transaction report, does not provide information relevant to broader industry trends or competitors.

Related Party Transactions

• Ira Liran indirectly beneficially owns 782,579 shares of common stock through the Ira Liran 2012 Family Trust.

Stakeholder Impact

• Shareholders may interpret the director's sale as a signal, potentially leading to minor negative sentiment, though the 10b5-1 plan provides context for the transaction.

Key Dates

Recommendation

While a director's sale of shares can sometimes be a negative signal, the execution under a Rule 10b5-1 plan suggests a pre-planned liquidity event rather than a reaction to new, undisclosed negative information. Without further context on the company's performance or other market factors, this single transaction does not warrant a strong buy or sell recommendation, thus a 'hold' is appropriate for existing investors. New investors should conduct further due diligence.

Keywords

Vita Coco Company, COCO, Ira Liran, Director, Insider Sale, Form 4, 10b5-1 Plan, Common Stock, Equity Transaction